Skip to main content
. Author manuscript; available in PMC: 2017 Nov 4.
Published in final edited form as: Vaccine. 2016 Sep 22;34(46):5656–5663. doi: 10.1016/j.vaccine.2016.09.021

Figure 2. Results of the pilot study.

Figure 2

Representative images of the paper-based HPV VLP immunoassay after 35 minutes for individuals who received (A) Three doses of HPV Vaccine, (B) Two doses of HPV vaccines, (C) One dose of HPV Vaccine and (D) No HPV vaccine. (E) Average signal-to-background ratio at each test zone stratified by number of HPV vaccines received.